Sodium channel blockers and uridine triphosphate: Effects on nasal potential difference in cystic fibrosis mice

European Respiratory Journal

Volumn 15, Issue 1, 2000, Pages 146-150

  Ghosal, S ^a   Taylor, C J ^a,c   Colledge, W H ^b   Ratcliff, R ^b   Evans, M J ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis mice; Nasal potential difference; Sodium channel blockers; Uridine triphosphate

Indexed keywords

AMILORIDE; CHLORIDE; LOPERAMIDE; SODIUM; SODIUM CHANNEL BLOCKING AGENT; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG ACTIVITY; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMILORIDE; ANIMALS; CHLORIDES; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; LOPERAMIDE; MEMBRANE POTENTIALS; MICE; MICE, INBRED CFTR; NASAL MUCOSA; SODIUM CHANNELS; URIDINE TRIPHOSPHATE;

EID: 0033978098     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15a27.x     Document Type: Article

References (30)

1. Welsh MJ, Fick RB. Cystic fibrosis. J Clin Invest 1987; 80: 1523-1526.
2. Puchelle E, Gaillard D, Ploton D, et al. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 1992; 7: 485-491.
3. - currents in normal and cystic fibrosis airway epithelial cells. J Biol Chem 1993; 268: 24779-24784.
4. + conductance in cystic fibrosis. Pflugers Arch 1995; 431: 1-9.
5. Rayner CF, Rutman A, Dewar A, Cole PJ, Wilson R. Ciliary disorientation in patients with chronic upper respiratory tract inflammation. Am J Respir Crit Care Med 1995; 151: 800-804.
6. Knowles MR, Church NL, Waltner WE, et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 1990; 322: 1189-1194.
7. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
8. Knowles MR, Robinson JM, Wood RE, et al. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 1997; 100: 2588-2595.
9. Mason S, Paradiso AM, Boucher RC. Regulation of transepithehal ion transport and intracellular calcium by extracellular adenosine triphosphate in human normal and cystic fibrosis airway epithelium. Br J Pharmacol 1991; 103: 1649-1656.
10. - currents by UTP and ATP in CFPAC-1 cells. Pflugers Arch 1994; 426: 534-541.
11. Noone PG, Knowles MR. Trends in therapy of abnormal airway epithelial ion and liquid transport. Monaldi Arch Chest Dis 1993; 48: 140-143.
12. Dorin JR, Dickinson P, Alton EW, et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 1992; 359: 211-215.
13. Colledge WH, Abella BS, Southern KW, et al. Generation and characterization of a delta F508 cystic fibrosis mouse model. Nature Genetics 1995; 10: 445-452.
14. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
15. Davidson DJ, Dorin JR, McLachlan G, et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genetics 1995; 9: 351-357.
16. Ghosal S, Taylor CJ, McGaw J. Modification of the nasal membrane potential difference with inhaled amiloride and loperamide in the CF mouse. Thorax 1996; 51: 1229-1232.
17. Unal-Maelger OH, Urbanek R. Status of determining the transepithehal potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis. Monatsschrift Kinderheilhmde 1988; 136: 76-80.
18. Hardcastle J, Hardcastle PT, Read NW, Redfern JS. The action of loperamide in inhibiting prostaglandin-induced intestinal secretion in the rat. Br J Pharmacol 1981; 74: 563-569.
19. ABPI compendium of data sheets. London, Datapharm Limited, 1996-97; pp. 452-648.
20. - secretion in nasal epithelia of CF mice. Am J Physiol 1994; 266: C1478-C1483.
21. Wilschanski MA, Rozmahel R, Beharry S, et al. In vivo measurements of ion transport in long living CF mice. Biochem Biophys Res Comm 1996; 219: 753-759.
22. Knowles MR, Clarke LL, Boucher RC. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. New Engl J Med 1991; 325: 533-538.
23. Davis CW, Dowell ML, Lethem M, Van-Scott M. Goblet cell degranulation in isolated canine tracheal epithehum: response to exogenous ATP, ADP, and adenosine. Am J Physiol 1992; 262: C1313-C1323.
24. Olivier KN, Bennett WD, Hohneker KW, et al. Acute safety and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate +/- amiloride in normal human adults. Am J Respir Crit Care Med 1996; 154: 217-223.
25. Brown HA, Lazarowski ER, Boucher RC, Harden TK. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5′ nucleotide receptor in human airway epithelial cells. Mol Pharmacol 1991; 40: 648-655.
26. Wilkinson GF, Purkiss JR, Boarder MR. The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phosphohpase C. Br J Pharmacol 1993; 108: 689-693.
27. 2+)-mobilizing receptors for ATP and UTP. Cell Calcium 1995; 17: 111-119.
28. Richards SM, Dora KA, Rattigan S, Colquhoun EQ, Clark MG. Role of extracellular UTP in the release of uracil from vasoconstricted hindlimb. Am J Physiol 1993; 264: H233-H237.
29. Clarke LL, Grubb BR, Yankaskas JR, Cotton CU, McKenzie A, Boucher RC. Relationship of a non-cystic fibrosis transmembrane conductance regulator mediated chloride conductance to organ-level disease in CFTR(-/-) mice. Proc Nafl Acad Sci USA 1994; 91: 479-483.
30. Dorin JR, Stevenson BJ, Fleming S, Dickinson P, Alton EW, Porteous DJ. Long term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild type CFTR gene expression. Mamm Genome 1994; 5: 465-472.